EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

40 hedge funds and large institutions have $101M invested in Eiger BioPharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10: →

more funds holding

Funds holding: →

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

Holders
40
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$8.43M
2
+$5.36M
3
+$4.18M
4
HCM
Highbridge Capital Management
New York
+$2.58M
5
SCM
Stonepine Capital Management
Oregon
+$2.09M

Top Sellers

1
-$1.52M
2
-$1.12M
3
-$607K
4
TCM
Tekla Capital Management
Massachusetts
-$341K
5
Millennium Management
Millennium Management
New York
-$178K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$162K
27
$152K
28
$140K
29
$78K
30
$77K
31
$45K
32
$42K
33
$21K
34
$10K
35
$7K
36
$4K
37
$2K
38
$2K
39
$879
40
–
41
–
42
–
43
–
44
–
1
2